Date
Title
View
16 Nov 16
SYGNIS AG launches TruePrimeTM Liquid Biopsy Kit targeting Oncology Research and Diagnostics
09 Nov 16
SYGNIS AG reports nine month results for the period ended September 30, 2016
02 Nov 16
SYGNIS to host Conference Call on November 09, 2016 to present nine month financial results for the period ended September 30, 2016
27 Oct 16
SYGNIS AG to receive EUR1.9 million non-dilutive R&D funding from the Spanish government
26 Oct 16
SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26 Oct 16
SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
26 Oct 16
SYGNIS AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
25 Oct 16
DGAP-DD: SYGNIS AG english
25 Oct 16
DGAP-DD: SYGNIS AG english
25 Oct 16
DGAP-DD: SYGNIS AG english
25 Oct 16
DGAP-DD: SYGNIS AG english
25 Oct 16
DGAP-DD: SYGNIS AG english